ID   KC1G1_HUMAN             Reviewed;         422 AA.
AC   Q9HCP0; Q5JPH1; Q96AE9; Q9HCP1;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 158.
DE   RecName: Full=Casein kinase I isoform gamma-1;
DE            Short=CKI-gamma 1;
DE            EC=2.7.11.1;
GN   Name=CSNK1G1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1L AND 1S).
RX   PubMed=11124537;
RA   Kusuda J., Hirai M., Tanuma R., Hashimoto K.;
RT   "Cloning, expression analysis and chromosome mapping of human casein
RT   kinase 1 gamma1 (CSNK1G1): identification of two types of cDNA
RT   encoding the kinase protein associated with heterologous carboxy-
RT   terminal sequences.";
RL   Cytogenet. Cell Genet. 90:298-302(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1L).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   FUNCTION AS CLSPN KINASE, AND MUTAGENESIS OF ASN-169.
RX   PubMed=21680713; DOI=10.1091/mbc.E11-01-0048;
RA   Meng Z., Capalbo L., Glover D.M., Dunphy W.G.;
RT   "Role for casein kinase 1 in the phosphorylation of Claspin on
RT   critical residues necessary for the activation of Chk1.";
RL   Mol. Biol. Cell 22:2834-2847(2011).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 45-352 IN COMPLEX WITH
RP   DB08325.
RA   Bunkoczi G., Rellos P., Das S., Savitsky P., Niesen F., Sobott F.,
RA   Fedorov O., Pike A.C.W., Von Delft F., Sundstrom M., Arrowsmith C.,
RA   Edwards A., Weigelt J., Knapp S.;
RT   "Structure of human casein kinase 1 gamma-1 in complex with (3-
RT   chloroanilino)-9-isopropylpurine (casp target).";
RL   Submitted (JUL-2011) to the PDB data bank.
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-206 AND ILE-329.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase. Casein kinases are
CC       operationally defined by their preferential utilization of acidic
CC       proteins such as caseins as substrates. It can phosphorylate a
CC       large number of proteins. Participates in Wnt signaling. Regulates
CC       fast synaptic transmission mediated by glutamate (By similarity).
CC       Phosphorylates CLSPN. {ECO:0000250, ECO:0000269|PubMed:21680713}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Repressed by 2-(2-hydroxyethylamino)-6-(3-
CC       chloroanilino)-9-isopropylpurine (DB08325).
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8TAP6:CEP76; NbExp=3; IntAct=EBI-1383814, EBI-742887;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-1383814, EBI-10172290;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1L;
CC         IsoId=Q9HCP0-1; Sequence=Displayed;
CC       Name=1S;
CC         IsoId=Q9HCP0-2; Sequence=VSP_004748;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. Casein kinase I subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB042563; BAB17839.1; -; mRNA.
DR   EMBL; AB042562; BAB17838.1; -; mRNA.
DR   EMBL; AL832551; CAI46142.1; -; mRNA.
DR   EMBL; CH471082; EAW77670.1; -; Genomic_DNA.
DR   EMBL; BC017236; AAH17236.2; -; mRNA.
DR   EMBL; BC130613; AAI30614.1; -; mRNA.
DR   EMBL; BC136504; AAI36505.1; -; mRNA.
DR   CCDS; CCDS10192.2; -. [Q9HCP0-1]
DR   RefSeq; NP_001316535.1; NM_001329606.1.
DR   RefSeq; NP_071331.2; NM_022048.4. [Q9HCP0-1]
DR   UniGene; Hs.646508; -.
DR   PDB; 2CMW; X-ray; 1.75 A; A=45-352.
DR   PDBsum; 2CMW; -.
DR   ProteinModelPortal; Q9HCP0; -.
DR   SMR; Q9HCP0; -.
DR   BioGrid; 119824; 16.
DR   IntAct; Q9HCP0; 9.
DR   MINT; MINT-4650731; -.
DR   STRING; 9606.ENSP00000305777; -.
DR   BindingDB; Q9HCP0; -.
DR   ChEMBL; CHEMBL2426; -.
DR   DrugBank; DB08325; 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE.
DR   GuidetoPHARMACOLOGY; 1999; -.
DR   iPTMnet; Q9HCP0; -.
DR   PhosphoSitePlus; Q9HCP0; -.
DR   SwissPalm; Q9HCP0; -.
DR   BioMuta; CSNK1G1; -.
DR   DMDM; 18202957; -.
DR   EPD; Q9HCP0; -.
DR   MaxQB; Q9HCP0; -.
DR   PaxDb; Q9HCP0; -.
DR   PeptideAtlas; Q9HCP0; -.
DR   PRIDE; Q9HCP0; -.
DR   DNASU; 53944; -.
DR   Ensembl; ENST00000303052; ENSP00000305777; ENSG00000169118. [Q9HCP0-1]
DR   Ensembl; ENST00000606225; ENSP00000475325; ENSG00000169118. [Q9HCP0-2]
DR   GeneID; 53944; -.
DR   KEGG; hsa:53944; -.
DR   UCSC; uc002anf.4; human. [Q9HCP0-1]
DR   CTD; 53944; -.
DR   GeneCards; CSNK1G1; -.
DR   HGNC; HGNC:2454; CSNK1G1.
DR   HPA; HPA018209; -.
DR   MIM; 606274; gene.
DR   neXtProt; NX_Q9HCP0; -.
DR   OpenTargets; ENSG00000169118; -.
DR   PharmGKB; PA26954; -.
DR   eggNOG; KOG1165; Eukaryota.
DR   eggNOG; ENOG410XNXP; LUCA.
DR   GeneTree; ENSGT00760000119040; -.
DR   HOGENOM; HOG000182054; -.
DR   HOVERGEN; HBG000176; -.
DR   InParanoid; Q9HCP0; -.
DR   KO; K08958; -.
DR   PhylomeDB; Q9HCP0; -.
DR   TreeFam; TF313349; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   SignaLink; Q9HCP0; -.
DR   SIGNOR; Q9HCP0; -.
DR   ChiTaRS; CSNK1G1; human.
DR   EvolutionaryTrace; Q9HCP0; -.
DR   GenomeRNAi; 53944; -.
DR   PRO; PR:Q9HCP0; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000169118; -.
DR   CleanEx; HS_CSNK1G1; -.
DR   ExpressionAtlas; Q9HCP0; baseline and differential.
DR   Genevisible; Q9HCP0; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0008360; P:regulation of cell shape; IBA:GO_Central.
DR   GO; GO:0016055; P:Wnt signaling pathway; IBA:GO_Central.
DR   InterPro; IPR022247; Casein_kinase-1_gamma_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12605; CK1gamma_C; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Wnt signaling pathway.
FT   CHAIN         1    422       Casein kinase I isoform gamma-1.
FT                                /FTId=PRO_0000192839.
FT   DOMAIN       44    315       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      50     58       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    164    164       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      73     73       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     344    344       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   VAR_SEQ     370    422       VVSSTNGELNVDDPTGAHSNAPITAHAEVEVVEEAKCCCFF
FT                                KRKRKKTAQRHK -> SLRTVTAEHYDVNNSAIWHRGRGT
FT                                (in isoform 1S).
FT                                {ECO:0000303|PubMed:11124537}.
FT                                /FTId=VSP_004748.
FT   VARIANT     206    206       R -> K (in dbSNP:rs55799101).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042084.
FT   VARIANT     329    329       V -> I (in dbSNP:rs55699712).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042085.
FT   MUTAGEN     169    169       N->A: Loss of kinase activity.
FT                                {ECO:0000269|PubMed:21680713}.
FT   STRAND       49     52       {ECO:0000244|PDB:2CMW}.
FT   STRAND       54     62       {ECO:0000244|PDB:2CMW}.
FT   TURN         64     66       {ECO:0000244|PDB:2CMW}.
FT   STRAND       69     76       {ECO:0000244|PDB:2CMW}.
FT   HELIX        84     94       {ECO:0000244|PDB:2CMW}.
FT   STRAND      104    110       {ECO:0000244|PDB:2CMW}.
FT   STRAND      113    119       {ECO:0000244|PDB:2CMW}.
FT   HELIX       125    131       {ECO:0000244|PDB:2CMW}.
FT   TURN        132    134       {ECO:0000244|PDB:2CMW}.
FT   HELIX       138    157       {ECO:0000244|PDB:2CMW}.
FT   HELIX       167    169       {ECO:0000244|PDB:2CMW}.
FT   STRAND      170    172       {ECO:0000244|PDB:2CMW}.
FT   TURN        175    178       {ECO:0000244|PDB:2CMW}.
FT   STRAND      183    185       {ECO:0000244|PDB:2CMW}.
FT   TURN        197    199       {ECO:0000244|PDB:2CMW}.
FT   TURN        215    217       {ECO:0000244|PDB:2CMW}.
FT   HELIX       220    223       {ECO:0000244|PDB:2CMW}.
FT   HELIX       230    246       {ECO:0000244|PDB:2CMW}.
FT   TURN        250    253       {ECO:0000244|PDB:2CMW}.
FT   HELIX       259    272       {ECO:0000244|PDB:2CMW}.
FT   HELIX       275    278       {ECO:0000244|PDB:2CMW}.
FT   TURN        279    281       {ECO:0000244|PDB:2CMW}.
FT   HELIX       284    295       {ECO:0000244|PDB:2CMW}.
FT   HELIX       304    317       {ECO:0000244|PDB:2CMW}.
FT   TURN        327    330       {ECO:0000244|PDB:2CMW}.
SQ   SEQUENCE   422 AA;  48511 MW;  B875922349B97645 CRC64;
     MDHPSREKDE RQRTTKPMAQ RSAHCSRPSG SSSSSGVLMV GPNFRVGKKI GCGNFGELRL
     GKNLYTNEYV AIKLEPIKSR APQLHLEYRF YKQLGSAGEG LPQVYYFGPC GKYNAMVLEL
     LGPSLEDLFD LCDRTFTLKT VLMIAIQLLS RMEYVHSKNL IYRDVKPENF LIGRQGNKKE
     HVIHIIDFGL AKEYIDPETK KHIPYREHKS LTGTARYMSI NTHLGKEQSR RDDLEALGHM
     FMYFLRGSLP WQGLKADTLK ERYQKIGDTK RNTPIEALCE NFPEEMATYL RYVRRLDFFE
     KPDYEYLRTL FTDLFEKKGY TFDYAYDWVG RPIPTPVGSV HVDSGASAIT RESHTHRDRP
     SQQQPLRNQV VSSTNGELNV DDPTGAHSNA PITAHAEVEV VEEAKCCCFF KRKRKKTAQR
     HK
//
